These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34911774)

  • 1. PRMT5 Deficiency Enforces the Transcriptional and Epigenetic Programs of Klrg1
    Zheng Y; Chen Z; Zhou B; Chen S; Han L; Chen N; Ma Y; Xie G; Yang J; Nie H; Shen L
    J Immunol; 2022 Jan; 208(2):501-513. PubMed ID: 34911774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRMT5 Inhibition Promotes PD-L1 Expression and Immuno-Resistance in Lung Cancer.
    Hu R; Zhou B; Chen Z; Chen S; Chen N; Shen L; Xiao H; Zheng Y
    Front Immunol; 2021; 12():722188. PubMed ID: 35111150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLRG1
    Herndler-Brandstetter D; Ishigame H; Shinnakasu R; Plajer V; Stecher C; Zhao J; Lietzenmayer M; Kroehling L; Takumi A; Kometani K; Inoue T; Kluger Y; Kaech SM; Kurosaki T; Okada T; Flavell RA
    Immunity; 2018 Apr; 48(4):716-729.e8. PubMed ID: 29625895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT5 Promotes Symmetric Dimethylation of RNA Processing Proteins and Modulates Activated T Cell Alternative Splicing and Ca
    Sengupta S; West KO; Sanghvi S; Laliotis G; Agosto LM; Lynch KW; Tsichlis PN; Singh H; Patrick KL; Guerau-de-Arellano M
    Immunohorizons; 2021 Oct; 5(10):884-897. PubMed ID: 34716181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression.
    Jiang Y; Yuan Y; Chen M; Li S; Bai J; Zhang Y; Sun Y; Wang G; Xu H; Wang Z; Zheng Y; Nie H
    Theranostics; 2021; 11(18):9162-9176. PubMed ID: 34522232
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection.
    Wilson DC; Matthews S; Yap GS
    J Immunol; 2008 May; 180(9):5935-45. PubMed ID: 18424713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 9. Protein arginine methyltransferase 5 promotes cholesterol biosynthesis-mediated Th17 responses and autoimmunity.
    Webb LM; Sengupta S; Edell C; Piedra-Quintero ZL; Amici SA; Miranda JN; Bevins M; Kennemer A; Laliotis G; Tsichlis PN; Guerau-de-Arellano M
    J Clin Invest; 2020 Apr; 130(4):1683-1698. PubMed ID: 32091410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective PRMT5 Inhibitors Suppress Human CD8
    Strobl CD; Schaffer S; Haug T; Völkl S; Peter K; Singer K; Böttcher M; Mougiakakos D; Mackensen A; Aigner M
    Mol Cancer Ther; 2020 Feb; 19(2):409-419. PubMed ID: 31712395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.
    Göthert JR; Eisele L; Klein-Hitpass L; Weber S; Zesewitz ML; Sellmann L; Röth A; Pircher H; Dührsen U; Dürig J
    Cancer Immunol Immunother; 2013 Nov; 62(11):1697-1709. PubMed ID: 24022692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
    Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
    Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of KLRG1 and CD127 defines distinct CD8
    Wu H; Tang X; Kim HJ; Jalali S; Pritchett JC; Villasboas JC; Novak AJ; Yang ZZ; Ansell SM
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34226281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency.
    Umeshappa CS; Nanjundappa RH; Xie Y; Freywald A; Xu Q; Xiang J
    Immunology; 2013 Apr; 138(4):298-306. PubMed ID: 23113741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
    Chen H; Lorton B; Gupta V; Shechter D
    Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2A-regulated epigenetic landscape promotes memory CD8 T cell differentiation.
    Schauder DM; Shen J; Chen Y; Kasmani MY; Kudek MR; Burns R; Cui W
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33859041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRMT5 Is Required for T Cell Survival and Proliferation by Maintaining Cytokine Signaling.
    Tanaka Y; Nagai Y; Okumura M; Greene MI; Kambayashi T
    Front Immunol; 2020; 11():621. PubMed ID: 32328070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon regulatory factor 4 deficiency in CD8
    Zou D; Fu J; Guo Z; Chen W
    Immunology; 2020 Dec; 161(4):364-379. PubMed ID: 32892353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of killer cell lectin-like receptor G1 expression on T cells.
    Robbins SH; Terrizzi SC; Sydora BC; Mikayama T; Brossay L
    J Immunol; 2003 Jun; 170(12):5876-85. PubMed ID: 12794113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prmt5 deficiency inhibits CD4+ T-cell Klf2/S1pr1 expression and ameliorates EAE disease.
    Zheng Y; Chen Z; Zhou B; Chen S; Chen N; Shen L
    J Neuroinflammation; 2023 Aug; 20(1):183. PubMed ID: 37533053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.